Organigram Global Inc.

TSX:OGI Canada Healthcare — Drug Manufacturers - Specialty & Generic

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummi…

1.1k employees organigram.ca
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the full company research view.
Ownership 2026-05-25
Yamanaka, James Hideo bought +$22k
Insider trading – 2026-05-25
1 insider · +$22k net
Ownership 2026-05-19
Guyatt, Gregory bought +$15k
Insider trading – 2026-05-19
1 insider · +$15k net
Results 2026-05-12
Interim MD&A - English.pdf
Results 2026-05-12
Interim financial statements/report – English.pdf
Results 2026-05-12
Organigram Reports Second Quarter Fiscal 2026 Results
News release - English.pdf
Results 2026-05-06
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
News release - English.pdf
Transactions 2026-04-28 Financing
Other material contracts - English.pdf
Ownership 2026-04-28
British American Tobacco p.l.c. bought +$112.5M
Insider trading – 2026-04-28
1 insider · +$112.5M net
Transactions 2026-04-27 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-04-15 M&A
Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
News release - English.pdf
Transactions 2026-03-31 M&A
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
News release - English.pdf
Transactions 2026-03-31 M&A
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
News release - English.pdf
Transactions 2026-03-23 M&A
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH
News release - English.pdf
Transactions 2026-03-10 M&A
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
News release - English.pdf
News 2026-03-05
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
News release - English.pdf
Transactions 2026-03-03 M&A
Organigram to Acquire Remaining Stake in Sanity Group for Up to €247.2 Million
Material change report - English.pdf
News 2026-02-24
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
News release - English.pdf
News 2026-02-20
Early warning report.pdf
Transactions 2026-02-20
Other material contracts - English.pdf
Transactions 2026-02-20
Other material contracts - English.pdf
News 2026-02-19
Notice.pdf
News 2026-02-19
Notice.pdf
News 2026-02-19
Letter from former auditor.pdf
News 2026-02-19
Letter from successor auditor.pdf
Transactions 2026-02-19 Financing
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
News release - English.pdf
Transactions 2026-02-18 M&A
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company
News release - English.pdf
Results 2026-02-10 Financials
Interim MD&A - English.pdf
Results 2026-02-10 Financials
Interim financial statements/report – English.pdf
Results 2026-02-10
Organigram Reports First Quarter Fiscal 2026 Results
News release - English.pdf
Results 2026-02-03
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026
News release - English.pdf
Transactions 2025-12-31 Financing
Organigram Extends Innovation Investment with Phylos
News release - English.pdf
Ownership 2025-12-22
5 insiders · −$27k net
Insider trading – 2025-12-22
5 insiders · −$27k net
News 2025-12-16
Code of conduct.pdf
Results 2025-12-16 Financials
Annual information form - English.pdf
Results 2025-12-16 Financials
Annual report - English.pdf
Results 2025-12-16 Financials
Annual MD&A - English.pdf
Results 2025-12-16 Financials
Audited annual financial statements – English.pdf
Results 2025-12-16
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results
News release - English.pdf
Results 2025-12-05
Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025
News release - English.pdf
Ownership 2025-11-03
2 insiders · −$40k net
Insider trading – 2025-11-03
2 insiders · −$40k net
News 2025-10-29
News release - English.pdf
Ownership 2025-10-29
De Luca, Paolo sold +$2k
Insider trading – 2025-10-29
1 insider · −$2k net
Ownership 2025-10-24
2 insiders · −$62k net
Insider trading – 2025-10-24
2 insiders · −$62k net
News 2025-10-21
News release - English.pdf
News 2025-10-09
News release - English.pdf
Ownership 2025-09-12
2 insiders · −$30k net
Insider trading – 2025-09-12
2 insiders · −$30k net
News 2025-09-02
News release - English.pdf
Results 2025-08-13 Financials
Interim MD&A - English.pdf
Results 2025-08-13 Financials
Interim financial statements/report – English.pdf
News 2025-08-13
News release - English.pdf
Ownership 2025-08-05
2 insiders · −$40k net
Insider trading – 2025-08-05
2 insiders · −$40k net
News 2025-08-01
News release - English.pdf
News 2025-07-08
News release - English.pdf
Ownership 2025-06-16
De Luca, Paolo sold +$12k
Insider trading – 2025-06-16
1 insider · −$12k net
News 2025-06-04
Material change report - English.pdf
Ownership 2025-05-16
John, Dexter sold +$25k
Insider trading – 2025-05-16
1 insider · −$25k net
Ownership 2025-04-08
2 insiders · +$12k net
Insider trading – 2025-04-08
2 insiders · +$12k net
Ownership 2024-10-29
2 insiders · −$63k net
Insider trading – 2024-10-29
2 insiders · −$63k net
Ownership 2024-09-13
De Luca, Paolo sold +$35k
Insider trading – 2024-09-13
1 insider · −$35k net
Ownership 2024-08-21
2 insiders · −$59k net
Insider trading – 2024-08-21
2 insiders · −$59k net
Ownership 2024-06-17
John, Dexter sold +$16k
Insider trading – 2024-06-17
1 insider · −$16k net

Showing 61 of 79 items in this period.